Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Ulcerative Colitis (UC)
Clinical trial register · Poland

Ulcerative Colitis (UC) Trials in Poland, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Poland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2692 matching records held by the registry are in this view. Synced 22 Oct 2026, 03:18 UTC
2692
Studies in scope
all four open statuses
1380
Recruiting now
open to new participants
509
Lead sponsors
across recruiting studies
Top sites
Katowice 6 Warsaw 6 Wroclaw 4 Sopot 4 Krakow 4
Narrow the registerReset
Recruitment status
Phase
Site location
Katowice6 Warsaw6 Wroclaw4 Sopot4 Krakow4
All 22 locations
Target enrolment
to

Ulcerative Colitis (UC) trials in Poland

10 of 2692 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Poland
Start
Recruiting
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
NCT07845487Ulcerative Colitis (UC), Severe Ulcerative Colitis, Moderate Ulcerative Colitis
Palisade Bio
Phase 2
204
Bydgoszcz, Elblag, Katowice, Kielce, Krakow, Kłodzko, Lodz, Lublin
2026-08-28
Recruiting
Mage Biologics
Phase 1/2
100
Katowice, Warsaw, Wroclaw
2026-04-01
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
NCT07415044Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate, Ulcerative Colitis, Active Severe
Eli Lilly and Company
Phase 2
1,431
Chorzów, Katowice, Kielce, Krakow, Lodz, Malbork, Nowy Targ, Poznan
2026-03-26
Recruiting
Microplastic Analysis in Pediatric Inflammatory Bowel Disease
NCT07141238Crohn Disease, Pediatric Inflammatory Bowel Diseases, Ulcerative Colitis (UC), Inflammatory Bowel Disease (IBD)
Medical University of Gdansk
Observational
40
Gdansk
2025-06-15
Recruiting
Odyssey Therapeutics, Inc.
Phase 2
57
Bydgoszcz, Chojnice, Katowice, Rzeszów, Sopot, Staszów, Warsaw, Wroclaw
2025-06-02
Not yet open
Liveome Inc.
Phase 1
15
Wroclaw
2025-03-24
Recruiting
Xencor, Inc.
Phase 1/2
270
Bydgoszcz, Katowice, Krakow, Nowy Targ, Sopot, Staszów, Szczecin, Warsaw
2024-10-10
Active, closed
Development and Validation of a New Paediatric Inflammatory Bowel Disease NUTrition Risk Score (PIBD-NUTS)
NCT06723418Inflammatory Bowel Diseases (IBD), Crohns Disease, Ulcerative Colitis (UC)
University of Glasgow
Observational
2,000
Warsaw
2024-06-15
Active, closed
AbbVie
Phase 3
1,242
Bydgoszcz, Torun, Krakow, Wroclaw, Warsaw, Sopot, Katowice, Tychy
2018-08-28
Active, closed
AbbVie
Phase 3
950
Torun, Warsaw, Sopot
2017-01-31
Rows per page Showing 1–10 of 10
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Polish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 22 October 2026. https://priyalifescience.com/clinical-trials-poland/condition/ulcerative-colitis-uc

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Poland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,692 studies in total at the last sync on 22 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 10 of those studies listing the condition Ulcerative Colitis (UC).

How many Ulcerative Colitis (UC) trials are recruiting in Poland?

6 of the 10 studies on this page are recruiting new participants as of the 22 Oct 2026, 03:18 UTC sync. A further 1 have not yet opened recruitment, 3 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Ulcerative Colitis (UC)), 10 studies
PhaseStudiesRecruitingShare
Phase 23330%
Observational2120%
Phase 1/22220%
Phase 32020%
Phase 11010%

Most active sponsors

Lead sponsors with the most studies (Ulcerative Colitis (UC))
Lead sponsorStudiesRecruiting
AbbVie20
Eli Lilly and Company11
Liveome Inc.10
Mage Biologics11
Medical University of Gdansk11
Odyssey Therapeutics, Inc.11
Palisade Bio11
University of Glasgow10
Xencor, Inc.11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.